DGX Quest Diagnostics Incorporated
Healthcare$195.09+0.66%ClosedMarket Cap: $21.60B
As of 2026-05-25
Valuation
P/E (TTM)
21.37
PEG
1.54
P/B
2.91
P/S
1.91
EV/EBITDA
14.23
DCF Value
$218.42
FCF Yield
6.1%
Div Yield
1.7%
Margins & Returns
Gross Margin
33.2%
Operating Margin
14.3%
Net Margin
9.1%
ROE
14.1%
ROA
6.1%
ROIC
8.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $2.90B | 32.5% | $399.0M | $252.0M | $— | $0.80 |
| Q4 null | $2.81B | 32.6% | $391.0M | $245.0M | $— | $0.80 |
| FY null | $11.04B | 31.9% | $1.60B | $992.0M | $— | $3.15 |
| Q3 null | $2.82B | 33.7% | $386.0M | $245.0M | $— | $0.80 |
| Q2 null | $2.76B | 34.2% | $438.0M | $282.0M | $— | $0.80 |
| Q1 null | $2.65B | 32.5% | $346.0M | $220.0M | $— | $0.75 |
| Q4 null | $2.62B | 32.7% | $361.0M | $222.0M | $— | $0.75 |
| FY null | $9.87B | 32.9% | $1.35B | $871.0M | $— | $2.96 |
| Q3 null | $2.49B | 32.6% | $330.0M | $226.0M | $— | $0.75 |
| Q2 null | $2.40B | 33.5% | $355.0M | $229.0M | $— | $0.75 |
| Q1 null | $2.37B | 32.6% | $300.0M | $194.0M | $— | $0.71 |
| Q4 2023 | $2.29B | 32.3% | $267.0M | $192.0M | $1.70 | $0.71 |